The Factors, the Impact and Treatment for Autism Spectrum Disorders Among Children
DOI:
https://doi.org/10.54097/ehss.v8i.4270Keywords:
autism spectrum disorder, preterm birth, sleep disorder, pharmacological treatments.Abstract
The prevalence of Autism Spectrum Disorders (ASD) is about 1% around the world. Due to the paucity of available data, until now researchers failed to identify the cause of the disease, but have identified it was related to genetic or environmental factors. This paper summarized what people currently knew about ASD, including the factors which caused ASD, the impacts that ASD affected patients and their families, and the treatment for curing ASD. It was found that ASD could be affected by genetic and physical conditions of fetuses and parents in the natal period, and for the patients, the ASD symptoms possibly affected their health and social problems of them and their parents. Nowadays, the treatments usually were used just to reduce the symptoms and risk factors of ASD instead of curing completely, which included pharmacological and other pedagogical. These findings were significant in adding further in-depth understandings of ASD and further developing more fitting treatment methods for it.
Downloads
References
A.O. Caglayan, Genetic causes of syndromic and non-syndromic autism, in: B. Dan(Eds.), Developmental Medicine & Child Neurology, vol. 52, 2010, pp. 130-138. DOI: https://doi-org.myaccess.library.utoronto.ca/10.1111/j.1469-8749.2009.03523.x
O. A. Al-Farsi, Y. M. Al-Farsi, M. M. Al-Sharbati & S. Al-Adawi, Stress, anxiety, and depression among parents of children with autism spectrum disorder in Oman: a case–control study, in: Dove Press Journal, Neuropsychiatric Disease and Treatment, vol. 2016, 2016, pp. 1943-1951. DOI: https://doi.org/10.2147/NDT.S107103
G.S. Young, J.N. Constantino, S. Dvorak, A. Belding, D. Gangi, A. Hill, M. Hill, M. Miller, C. Parikh, A.J. Schwichtenberg, E. Solis, S. Ozonoff, A video-based measure to identify autism risk in infancy, in: E. Sonuga-Barke, the journal of child psychology and psychiatry, vol.61, 2020, pp. 88-94.DOI:https://doi-org.myaccess.library.utoronto.ca/10.1111/jcpp.13105
C.V.A. Toscano, L. Barros, A.B. Lima, T. Nunes, H.M. Carvalho & J. M. Gaspar, Neuroinflammation in autism spectrum disorders: Exercise as a “pharmacological” tool, in: F.R. Volkmar, L.K. Koegel(Eds.), Journal of Autism and Development Disorders, vol. 129, Springer, Berlin, Heidelberg, 2021, pp. 63-74. DOI: https://doi.org/10.1016/j.neubiorev.2021.07.023
R.P. Goin-Kochel, E. Fombonne, S.S. Mire, C.G. Minard, L.C. Sahni, R.M. Cunningham & J.A. Boom, Beliefs about causes of autism and vaccine hesitancy among parents of children with autism spectrum disorder, in: G.A. Poland(Eds.), Vaccine, Vol. 38, 2020, pp. 6327-6333. DOI: https://doi.org/10.1016/j.vaccine.2020.07.034
V. Guinchat, P. Thorsen, C. Laurent, C. Cans, N. Bodeau & D. Cohen, Pre‐, peri‐ and neonatal risk factors for autism, in: Munksgaard International Publishers, Acta Obstertricia Et Gynecologica Scandinavica, vol. 91, 2012, pp. 287-300. DOI: https://doi-org.myaccess.library.utoronto.ca/10.1111/j.1600-0412.2011.01325.x
D. Adams, J. Paynter, M. Clark, J. Roberts & D. Keen, The Developmental Behaviour Checklist (DBC) Profile in Young Children on the Autism Spectrum: The Impact of Child and Family Factors, in: F.R. Volkmar, L.K. Koegel(Eds.), Journal of Autism and Development Disorders, vol. 49, Springer, Berlin, Heidelberg, 2019, pp. 3426-3439. DOI: https://doi-org.myaccess.library.utoronto.ca/10.1007/s10803-019-04067-0
C.M. Schroder, B.A. Malow, A. Maras, R.D. Melmed, R.L. Finding, T.N. Breddy, S. Shahmoon, N. Zisapel & P. Gringras, Pediatric Prolonged-Release Melatonin for Sleep in Children with Autism Spectrum Disorder: Impact on Child Behavior and Caregiver’s Quality of Life, in: F.R. Volkmar, L.K. Koegel(Eds.), Journal of Autism and Development Disorders, vol. 49, Springer, Berlin, Heidelberg, 2019, pp. 3218-3230. DOI: https://doi-org.myaccess.library.utoronto.ca/10.1007/s10803-019-04046-5
E.G. Duerden, H.K. Oatley, K.M. Mak-Fan, P.A. McGrath, M.J. Taylor, P. Szatmari & S.W. Roberts, Risk Factors Associated with Self-Injurious Behaviors in Children and Adolescents with Autism Spectrum Disorders, in: F.R. Volkmar, L.K. Koegel(Eds.), Journal of Autism and Development Disorders, vol. 42, Springer, Berlin, Heidelberg, 2012, pp. 2460-2470. DOI: https://doi-org.myaccess.library.utoronto.ca/10.1007/s10803-012-1497-9
B. Zablotsky, C.P. Bradshaw, C.M. Anderson & P. Law, Risk factors for bullying among children with autism spectrum disorders, in: SAGE, Autism, vol. 18, 2013, pp. 419-427. DOI: utoronto.ca/10.1177%2F1362361313477920
D.J. Posey, K.A. Stigler, C.A. Erickson & C.J. McDougle, Antipsychotics in the treatment of autism, in: the journal of clinical investigation, Vol: 118, 2008, pp. 6-14. DOI: https://doi.org/10.1172/JCI32483
N. Bobrowski-Khoury, V. T. Ramaekers, J. M. Sequeira & E. V. Quadros, Folate Receptor Alpha Autoantibodies in Autism Spectrum Disorders: Diagnosis, Treatment and Prevention, in: Journal of personalized medicine, Vol. 11, 2021, pp.710. : https://doi.org/10.3390/jpm11080710
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
